GPT2 Gene (Glutamic Pyruvate Transaminase 2)

Comprehensive gene card for GPT2, encoding alanine aminotransferase 2, with links to NCBI, Ensembl, UniProt, OMIM, HGNC, COSMIC, and ClinVar.

Gene Information Card

Symbol GPT2
Full Name Glutamic pyruvate transaminase (alanine aminotransferase) 2
Gene Type Protein coding
Chromosomal Location 16q12.1
NCBI Gene ID 84706 ncbi.nlm.nih.gov/gene/84706
Ensembl ID ENSG00000166123
UniProt ID Q8TD30
OMIM ID 138210
HGNC ID 18062
Aliases ALT2, GPT 2, alanine aminotransferase 2

Description

The GPT2 gene encodes glutamic pyruvate transaminase 2 (also known as alanine aminotransferase 2), a mitochondrial enzyme that catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. This enzyme plays a key role in amino acid metabolism and gluconeogenesis. Mutations in GPT2 are associated with autosomal recessive intellectual developmental disorder with microcephaly and spastic paraplegia (IDDMS).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual developmental disorder with microcephaly and spastic paraplegia (IDDMS) Loss-of-function mutations in GPT2 impair alanine metabolism and mitochondrial function, leading to neurodevelopmental deficits. OMIM #616281; ClinVar
Autosomal recessive intellectual disability Biallelic GPT2 variants cause reduced enzyme activity, affecting brain development. ClinVar; PubMed: 27040691

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.3 nTPM Medium
Kidney 8.7 nTPM Medium
Brain 5.1 nTPM Low
Heart 4.2 nTPM Low
Skeletal muscle 3.8 nTPM Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 nTPM Liver cancer cell line, high expression
HEK 293 6.4 nTPM Embryonic kidney, moderate expression
SH-SY5Y 4.1 nTPM Neuroblastoma, low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1072C>T (p.Arg358*) Nonsense Rare Loss of function; associated with IDDMS
c.382G>A (p.Gly128Arg) Missense Rare Reduced enzyme activity; pathogenic in ClinVar
c.1045C>T (p.Arg349Trp) Missense Rare Likely pathogenic; reported in IDDMS
Mutation functional classification

Loss of Function (LOF)

Nonsense and missense mutations that reduce or abolish alanine aminotransferase activity, leading to metabolic imbalance and neurodevelopmental disease.

Gain of Function (GOF)

No gain-of-function mutations reported for GPT2.

Dominant Negative (DN)

No dominant-negative mutations reported; all pathogenic variants are recessive.

Pathways

Alanine metabolism (Reactome: R-HSA-71291)
Gluconeogenesis (Reactome: R-HSA-70263)

Protein Summary

GPT2 encodes alanine aminotransferase 2 (ALT2), a 523-amino acid mitochondrial enzyme. It catalyzes the reversible conversion of alanine and 2-oxoglutarate to pyruvate and glutamate, playing a crucial role in amino acid homeostasis and gluconeogenesis. The protein is highly expressed in liver and kidney, with lower levels in brain and heart. Loss-of-function mutations cause autosomal recessive intellectual developmental disorder with microcephaly and spastic paraplegia (IDDMS).

Related Products

Product name Cat.No. Species Gene ID
GPT2 Knockout HEK293 Cell Line EDJ-KQ10175 Human 84706 Details Get a Quote
ANGPT2 Knockout HEK293 Cell Line EDC07528 Human 285 Details Get a Quote
GPT2 Knockout A-549 Cell Line EDJ-KQ37286 Human 84706 Details Get a Quote
GPT2 Knockout HCT 116 Cell Line EDJ-KQ37287 Human 84706 Details Get a Quote
GPT2 Knockout HeLa Cell Line EDJ-KQ37288 Human 84706 Details Get a Quote
ANGPT2 Knockout HeLa Cell Line EDJ-KQ52619 Human 285 Details Get a Quote
ANGPT2 Knockout A-549 Cell Line EDJ-KQ61098 Human 285 Details Get a Quote
ANGPT2 Knockout HCT 116 Cell Line EDJ-KQ69581 Human 285 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: